0000899243-22-020283.txt : 20220531
0000899243-22-020283.hdr.sgml : 20220531
20220531202350
ACCESSION NUMBER: 0000899243-22-020283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220526
FILED AS OF DATE: 20220531
DATE AS OF CHANGE: 20220531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Konstantinov Konstantin
CENTRAL INDEX KEY: 0001774649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 22985508
MAIL ADDRESS:
STREET 1: C/O CODIAK BIOSCIENCES, INC.
STREET 2: 500 TECHNOLOGY SQUARE, 9TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-26
0
0000730272
REPLIGEN CORP
RGEN
0001774649
Konstantinov Konstantin
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
1
0
0
0
Common Stock
2022-05-26
4
A
0
534
0.00
A
534
D
Stock Option (Right to Buy)
159.17
2022-05-26
4
A
0
1298
0.00
A
2023-05-26
2032-05-26
Common Stock
1298
1298
D
Stock Option (Right to Buy)
159.17
2022-05-26
4
A
0
2498
0.00
A
2023-05-26
2032-05-26
Common Stock
2498
2498
D
Mr. Konstantinov was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 26, 2023, one year from the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Award vests in full on May 26, 2023, one year from grant date.
The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period.
/s/ Kimberly Brown (Attorney in Fact)
2022-05-31